INS and Hyperglycemia: In a Cox proportional hazards model adjusted for diabetes mellitus, imatinib treatment was associated with a reduced hazard of severe hyperglycaemia and subsequent need for insulin administration (hazard ratio (HR) 0.54, 95% CI 0.32–0.93; p = 0.025; Fig. 1A).